![Eric Bednarski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Bednarski
Direktor/Vorstandsmitglied bei
MDXHEALTH SA
Profil
Eric Bednarski was the founder of Ampla Pharmaceuticals, Inc. (2006) and Prexa Pharmaceuticals, Inc. (2006) with the title of Director.
Current jobs include Chairman at Tarsa Therapeutics, Inc., Director at Biotheranostics, Inc., Non-Independent Non-Executive Director at MDxHealth SA (2020), Director at Neurolens, Inc., Partner at MVM Partners LLC (2008), and Partner at MVM Partners LLP (2008).
Former jobs include Director at SOLX, Inc., Non-Executive Director at Nxera Pharma UK Ltd., Director-Corporate Finance Group at Silicon Valley Bank, Director at AccuVein, Inc., Independent Director at OptiNose, Inc. (2021-2025), Principal at Advent International LP (2001-2007), Principal at SVB Asset Management, Principal at DuPont Merck Pharmaceutical Co., and Partner at Synthesis Capital.
Education includes an undergraduate degree from Brown University and a doctorate from the University of California.
Aktive Positionen von Eric Bednarski
| Unternehmen | Position | Beginn |
|---|---|---|
| MDXHEALTH SA | Direktor/Vorstandsmitglied | 30.07.2020 |
Neurolens, Inc.
 Neurolens, Inc. Electronic ComponentsElectronic Technology Develops prescription lenses | Direktor/Vorstandsmitglied | - |
MVM Partners LLC
 MVM Partners LLC Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01.01.2008 |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Direktor/Vorstandsmitglied | - |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral treatment for post-menopausal osteoporosis | Vorsitzender | 21.10.2009 |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Private Equity Investor | 01.01.2008 |
Ehemalige bekannte Positionen von Eric Bednarski
| Unternehmen | Position | Ende |
|---|---|---|
| OPTINOSEPAR | Direktor/Vorstandsmitglied | 21.05.2025 |
Advent International LP
 Advent International LP Investment ManagersFinance Advent invests in companies located across the globe. The firm targets companies operating in the fields of business & financial services, healthcare, industrial and technology services. It provides financing for leveraged buyout, recapitalizations, growth and public to private transactions. It also acquires majority and minority ownership. | Private-Equity-Analyst | 01.05.2007 |
SVB Asset Management
 SVB Asset Management Investment ManagersFinance SVB Asset Management utilizes both top-down and bottom-up portfolio management approaches. Their investment process includes quantitative and qualitative analysis using its own and third-party proprietary systems and methods. The firm offers three primary investment strategies: Corporate Cash Management Strategy, Total Return Strategy and ESG Strategy. | Corporate Officer/Principal | 31.12.2000 |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Eric Bednarski
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
19
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 19 |
|---|---|
Advent International LP
Advent International LP Investment ManagersFinance Advent invests in companies located across the globe. The firm targets companies operating in the fields of business & financial services, healthcare, industrial and technology services. It provides financing for leveraged buyout, recapitalizations, growth and public to private transactions. It also acquires majority and minority ownership. | Finance |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
MDxHealth SA
 MDxHealth SA Medical SpecialtiesHealth Technology Develops and commercializes epigenetic tests & services for cancer assessment | Health Technology |
Ampla Pharmaceuticals, Inc.
 Ampla Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the drug discovery of novel oral small molecule drugs for treatment of diabetes and metabolism disorders | Health Technology |
Prexa Pharmaceuticals, Inc.
 Prexa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral small molecule monoamine reuptake inhibitors | Health Technology |
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SVB Asset Management
SVB Asset Management Investment ManagersFinance SVB Asset Management utilizes both top-down and bottom-up portfolio management approaches. Their investment process includes quantitative and qualitative analysis using its own and third-party proprietary systems and methods. The firm offers three primary investment strategies: Corporate Cash Management Strategy, Total Return Strategy and ESG Strategy. | Finance |
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm targets companies operating in the fields of healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Finance |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
SOLX, Inc.
 SOLX, Inc. Medical SpecialtiesHealth Technology Specializes in management and surgical treatment of glaucoma | Health Technology |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
Silicon Valley Bank
 Silicon Valley Bank Regional BanksFinance Provides commercial banking services | Finance |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral treatment for post-menopausal osteoporosis | Health Technology |
AccuVein, Inc.
 AccuVein, Inc. Medical SpecialtiesHealth Technology Develops products that aid in the visualization of peripheral vasculature | Health Technology |
Synthesis Capital
 Synthesis Capital Investment ManagersFinance Synthesis Capital invests in US and European-based companies. The firm targets companies operating in the fields of bio-pharmaceutical and medical technology sectors. It provides financing for seed, early and late stage capital requirements. | Finance |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MVM Partners LLC
MVM Partners LLC Investment ManagersFinance Functions as an alternative investment manager | Finance |
Neurolens, Inc.
Neurolens, Inc. Electronic ComponentsElectronic Technology Develops prescription lenses | Electronic Technology |
